Prednisolone Drug Interactions
181Total Interactions
139Severe
20Moderate
0Mild
| Drug | Severity | Summary |
|---|---|---|
| Aceclofenac | SEVERE | Aceclofenac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufac... |
| Amifampridine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Amiodarone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Amisulpride | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Anagrelide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Apalutamide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Apomorphine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Aripiprazole | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Arsenic trioxide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Artemether | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Artenimol | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Atazanavir | SEVERE | Atazanavir is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or m... |
| Atezolizumab | SEVERE | Prednisolone might affect the efficacy of Atezolizumab. Manufacturer advises use with caution or ... |
| Atracurium | SEVERE | Prednisolone is predicted to decrease the effects of Atracurium. Manufacturer makes no recommenda... |
| Bacillus Calmette-Guérin vaccine | SEVERE | Bacillus Calmette-Guérin vaccine is predicted to increase the risk of generalised infection (poss... |
| Bedaquiline | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Benzydamine | SEVERE | Benzydamine increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufac... |
| Bosutinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Bromfenac | SEVERE | Bromfenac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Cabozantinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Celecoxib | SEVERE | Celecoxib increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Ceritinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Chikungunya vaccine (live) | SEVERE | Chikungunya vaccine (live) is predicted to increase the risk of generalised infection (possibly l... |
| Chlorpromazine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Cholera vaccine (live) | SEVERE | Cholera vaccine (live) is predicted to increase the risk of generalised infection (possibly life-... |
| Cisatracurium | SEVERE | Prednisolone is predicted to decrease the effects of Cisatracurium. Manufacturer makes no recomme... |
| Citalopram | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Clarithromycin | SEVERE | Clarithromycin is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid ... |
| Clomipramine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Cobicistat | SEVERE | Cobicistat is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or m... |
| Crizotinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Darunavir | SEVERE | Darunavir is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or mo... |
| Dasatinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Deferasirox | SEVERE | Prednisolone is predicted to increase the risk of gastrointestinal bleeding when given with Defer... |
| Delamanid | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Dengue vaccine | SEVERE | Dengue vaccine is predicted to increase the risk of generalised infection (possibly life-threaten... |
| Desflurane | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Dexketoprofen | SEVERE | Dexketoprofen increases the risk of gastrointestinal bleeding when given with Prednisolone. Manuf... |
| Diclofenac | SEVERE | Diclofenac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufact... |
| Digoxin | SEVERE | Prednisolone is predicted to increase the risk of Digoxin toxicity when given with Digoxin. Manuf... |
| Dinutuximab | SEVERE | Prednisolone is predicted to increase the risk of immunosuppression when given with Dinutuximab. ... |
| Disopyramide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Dronedarone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Droperidol | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Efavirenz | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Encorafenib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Entrectinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Eribulin | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Erlotinib | SEVERE | Erlotinib is predicted to increase the risk of gastrointestinal perforation when given with Predn... |
| Erythromycin | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Escitalopram | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Etodolac | SEVERE | Etodolac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactur... |
| Etoricoxib | SEVERE | Etoricoxib increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufact... |
| Fluconazole | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Flurbiprofen | SEVERE | Flurbiprofen increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufa... |
| Fosamprenavir | SEVERE | Fosamprenavir is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid o... |
| Glasdegib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Haloperidol | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Hydroxychloroquine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Hydroxyzine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ibuprofen | SEVERE | Ibuprofen increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Idelalisib | SEVERE | Idelalisib is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or m... |
| Indometacin | SEVERE | Indometacin increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufac... |
| Influenza vaccine (live) | SEVERE | Influenza vaccine (live) is predicted to increase the risk of generalised infection (possibly lif... |
| Inotuzumab ozogamicin | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ipilimumab | SEVERE | Prednisolone might affects the efficacy of Ipilimumab. Manufacturer advises use with caution or a... |
| Isoflurane | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Itraconazole | SEVERE | Itraconazole is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or... |
| Ivosidenib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ketoconazole | SEVERE | Ketoconazole is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or... |
| Ketoprofen | SEVERE | Ketoprofen increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufact... |
| Ketorolac | SEVERE | Ketorolac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Lapatinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Lenacapavir | SEVERE | Lenacapavir is predicted to increase the concentration of Prednisolone. Manufacturer advises adju... |
| Lenvatinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Levomepromazine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Lopinavir | SEVERE | Lopinavir is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or mo... |
| Measles, mumps and rubella vaccine | SEVERE | Measles, mumps and rubella vaccine is predicted to increase the risk of generalised infection (po... |
| Mefenamic acid | SEVERE | Mefenamic acid increases the risk of gastrointestinal bleeding when given with Prednisolone. Manu... |
| Meloxicam | SEVERE | Meloxicam increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Methadone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Mifamurtide | SEVERE | Prednisolone is predicted to decrease the efficacy of Mifamurtide. Manufacturer advises avoid. |
| Mivacurium | SEVERE | Prednisolone is predicted to decrease the effects of Mivacurium. Manufacturer makes no recommenda... |
| Moxifloxacin | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Nabumetone | SEVERE | Nabumetone increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufact... |
| Naproxen | SEVERE | Naproxen increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactur... |
| Natalizumab | SEVERE | Prednisolone might increase the risk of generalised infection (possibly life-threatening) when gi... |
| Nepafenac | SEVERE | Nepafenac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Nicorandil | SEVERE | Prednisolone increases the risk of gastrointestinal perforation when given with Nicorandil. Manuf... |
| Nilotinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Nirmatrelvir | SEVERE | Nirmatrelvir boosted with ritonavir is predicted to increase the concentration of Prednisolone. M... |
| Nivolumab | SEVERE | Prednisolone might affects the efficacy of Nivolumab. Manufacturer advises use with caution or av... |
| Ondansetron | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Osilodrostat | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Osimertinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Paliperidone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Pancuronium | SEVERE | Prednisolone is predicted to decrease the effects of Pancuronium. Manufacturer makes no recommend... |
| Panobinostat | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Parecoxib | SEVERE | Parecoxib increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Pasireotide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Pazopanib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Pembrolizumab | SEVERE | Prednisolone might affect the efficacy of Pembrolizumab. Manufacturer advises use with caution or... |
| Phenazone | SEVERE | Phenazone increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Pimozide | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Piroxicam | SEVERE | Piroxicam increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Posaconazole | SEVERE | Posaconazole is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or... |
| Promethazine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Quinine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Quizartinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ranolazine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ribociclib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ritonavir | SEVERE | Ritonavir is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or mo... |
| Rocuronium | SEVERE | Prednisolone is predicted to decrease the effects of Rocuronium. Manufacturer makes no recommenda... |
| Rotavirus vaccine | SEVERE | Rotavirus vaccine is predicted to increase the risk of generalised infection (possibly life-threa... |
| Selpercatinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Serplulimab | SEVERE | Prednisolone might affect the efficacy of Serplulimab. Manufacturer advises use with caution or a... |
| Sevoflurane | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Sorafenib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Sotalol | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Sulindac | SEVERE | Sulindac increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactur... |
| Sunitinib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Suxamethonium | SEVERE | Prednisolone is predicted to decrease the effects of Suxamethonium. Manufacturer makes no recomme... |
| Tenoxicam | SEVERE | Tenoxicam increases the risk of gastrointestinal bleeding when given with Prednisolone. Manufactu... |
| Tetrabenazine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Tiaprofenic acid | SEVERE | Tiaprofenic acid increases the risk of gastrointestinal bleeding when given with Prednisolone. Ma... |
| Tolfenamic acid | SEVERE | Tolfenamic acid increases the risk of gastrointestinal bleeding when given with Prednisolone. Man... |
| Tolterodine | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Toremifene | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Tucatinib | SEVERE | Tucatinib is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or mo... |
| Typhoid vaccine (live) | SEVERE | Typhoid vaccine (live) is predicted to increase the risk of generalised infection (possibly life-... |
| Vandetanib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Vardenafil | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Varicella-zoster vaccine | SEVERE | Varicella-zoster vaccine is predicted to increase the risk of generalised infection (possibly lif... |
| Vecuronium | SEVERE | Prednisolone is predicted to decrease the effects of Vecuronium. Manufacturer makes no recommenda... |
| Vemurafenib | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Vernakalant | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Voclosporin | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Voriconazole | SEVERE | Voriconazole is predicted to increase the exposure to Prednisolone. Manufacturer advises avoid or... |
| Yellow fever vaccine | SEVERE | Yellow fever vaccine is predicted to increase the risk of generalised infection (possibly life-th... |
| Acenocoumarol | MODERATE | Prednisolone is predicted to increase the effects of Acenocoumarol. Manufacturer advises monitor ... |
| Aspirin | MODERATE | Prednisolone is predicted to decrease the concentration of Aspirin (high-dose) and Aspirin (high-... |
| Carbamazepine | MODERATE | Carbamazepine is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor... |
| Choline salicylate | MODERATE | Prednisolone is predicted to decrease the concentration of Choline salicylate. Manufacturer makes... |
| Enzalutamide | MODERATE | Enzalutamide is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor ... |
| Fosphenytoin | MODERATE | Fosphenytoin is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor ... |
| Glycerol phenylbutyrate | MODERATE | Prednisolone potentially opposes the effects of Glycerol phenylbutyrate. Manufacturer advises mon... |
| Lumacaftor | MODERATE | Lumacaftor is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor an... |
| Mifepristone | MODERATE | Mifepristone is predicted to decrease the efficacy of Prednisolone. Manufacturer advises use with... |
| Mitotane | MODERATE | Mitotane is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor and ... |
| Phenindione | MODERATE | Prednisolone is predicted to increase the effects of Phenindione. Manufacturer advises monitor INR. |
| Phenobarbital | MODERATE | Phenobarbital is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor... |
| Phenytoin | MODERATE | Phenytoin is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor and... |
| Primidone | MODERATE | Primidone is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor and... |
| Rifampicin | MODERATE | Rifampicin is predicted to decrease the exposure to Prednisolone. Manufacturer advises monitor an... |
| Sodium phenylbutyrate | MODERATE | Prednisolone potentially decreases the effects of Sodium phenylbutyrate. Manufacturer advises mon... |
| Somapacitan | MODERATE | Prednisolone might decrease the efficacy of Somapacitan. Manufacturer advises monitor and adjust ... |
| Somatrogon | MODERATE | Prednisolone might decrease the efficacy of Somatrogon. Manufacturer advises monitor and adjust d... |
| Somatropin | MODERATE | Prednisolone is predicted to decrease the effects of Somatropin. Manufacturer advises monitor. |
| Warfarin | MODERATE | Prednisolone is predicted to increase the effects of Warfarin. Manufacturer advises monitor INR. |
| Aminophylline | LOW | Both Prednisolone and Aminophylline can increase the risk of hypokalaemia. |
| Amphotericin B | LOW | Both Prednisolone and Amphotericin B can increase the risk of hypokalaemia. |
| Bendroflumethiazide | LOW | Both Prednisolone and Bendroflumethiazide can increase the risk of hypokalaemia. |
| Bumetanide | LOW | Both Prednisolone and Bumetanide can increase the risk of hypokalaemia. |
| Chlorothiazide | LOW | Both Prednisolone and Chlorothiazide can increase the risk of hypokalaemia. |
| Chlortalidone | LOW | Both Prednisolone and Chlortalidone can increase the risk of hypokalaemia. |
| Formoterol | LOW | Both Prednisolone and Formoterol can increase the risk of hypokalaemia. |
| Furosemide | LOW | Both Prednisolone and Furosemide can increase the risk of hypokalaemia. |
| Hydrochlorothiazide | LOW | Both Prednisolone and Hydrochlorothiazide can increase the risk of hypokalaemia. |
| Hydroflumethiazide | LOW | Both Prednisolone and Hydroflumethiazide can increase the risk of hypokalaemia. |
| Indacaterol | LOW | Both Prednisolone and Indacaterol can increase the risk of hypokalaemia. |
| Indapamide | LOW | Both Prednisolone and Indapamide can increase the risk of hypokalaemia. |
| Isoprenaline | LOW | Both Prednisolone and Isoprenaline can increase the risk of hypokalaemia. |
| Metolazone | LOW | Both Prednisolone and Metolazone can increase the risk of hypokalaemia. |
| Olodaterol | LOW | Both Prednisolone and Olodaterol can increase the risk of hypokalaemia. |
| Salbutamol | LOW | Both Prednisolone and Salbutamol can increase the risk of hypokalaemia. |
| Salmeterol | LOW | Both Prednisolone and Salmeterol can increase the risk of hypokalaemia. |
| Terbutaline | LOW | Both Prednisolone and Terbutaline can increase the risk of hypokalaemia. |
| Theophylline | LOW | Both Prednisolone and Theophylline can increase the risk of hypokalaemia. |
| Torasemide | LOW | Both Prednisolone and Torasemide can increase the risk of hypokalaemia. |
| Vilanterol | LOW | Both Prednisolone and Vilanterol can increase the risk of hypokalaemia. |
| Xipamide | LOW | Both Prednisolone and Xipamide can increase the risk of hypokalaemia. |
Check Prednisolone against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker